And thus far no valualtion projections have taken into account two important items; highly likely National Security stockpile as mentioned a couple times by POTUS so as to not be caught again unprepared, and secondly the new possible testing market as described by Dr. Pat in the new patent application regarding Ramses markers. So what better news than receiving dual income from both testing and treating. This is mindblowing when extrapolated to include other indications beyond COVID. The company just keeps getting better.
Market Data 
Markets 
AI
